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Although most patients with multisegmental arterial
occlusive disease of the lower extremities only require
reconstruction of the suprainguinal lesions, as many as one
third of patients may require additional infrainguinal arte-
rial reconstruction (IAR) to obtain adequate clinical
improvement.5 Patients requiring multilevel arterial
reconstruction for lower-extremity ischemia may have a
higher risk for perioperative complications, in particular
after extensive aortoiliac reconstructive surgery. IAA alone
has been described as an effective adjunct when combined
with IAR in appropriate patients.6-8 Few reports have
described the use of iliac artery stenting (IAS) in combi-
nation with infrainguinal bypass procedures, and its effect
on the outcome and long-term results of IARs is
unknown.9-12
The TransAtlantic Inter-Society Consensus (TASC)
working group introduced a new morphologic stratifica-
tion of iliac lesions as an improvement over the outdated
classifications, outmoded by stent use (not considered at
the time of such classifications) and additional experience
with lesion-specific anatomy.13 Endovascular procedures
are the treatment of choice for type A lesions, and surgery
is the procedure of choice for type D lesions. Although
type B and type C lesions are more frequently treated with
endovascular procedures, there is not definitive evidence
Iliac artery angioplasty alone (IAA) is an established
treatment of aortoiliac occlusive disease. It is generally
applied to more focal lesions.1 Despite the safety and the
reasonable results with balloon angioplasty alone, acute
occlusions and early restenosis limit the long-term success.
Stent placement after angioplasty has been used as a means
of improving the initial technical success rates and may
decrease the risk of long-term failure.2,3 However, aortoil-
iac reconstructive surgery continues to offer the best long-
term results for patients with aortoiliac occlusive disease,
compromised only by the higher perioperative morbidity
and mortality and late graft limb failures.4
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Objective: Iliac artery angioplasty (IAA) is an effective adjunct when combined with infrainguinal arterial reconstruc-
tions (IARs) in appropriate patients with multilevel occlusive disease. However, the effect of iliac artery stenting (IAS)
on the outcome of patients undergoing distal bypass procedures is not defined. The purpose of this study was to esti-
mate the influence of previous IAS for iliac occlusive disease on the outcome of IARs, compared with those after IAA
alone or aortofemoral bypass grafting procedures (AFBs).
Methods: During a 5-year period (1995-2000), 105 patients with previous intervention for iliac occlusive disease under-
went 120 IARs. The criteria prepared by the Ad Hoc Committee on Reporting Standards (Society for Vascular
Surgery/International Society for Cardiovascular Surgery) were followed to define the variables. The TransAtlantic
Inter-Society Consensus classification was used to characterize the type of iliac lesions. Univariate (Kaplan-Meier) and
multivariate analyses (Cox proportional hazards model) were used to determine the association between preoperative
variables and cumulative primary patency.
Results: Forty-five IARs were performed in patients with an earlier IAS repair, 33 in patients with an earlier IAA repair,
and 42 in patients with an earlier AFB repair. There were not significant differences between patients in the IAS and
IAA groups, except for a more frequent use of polytetrafluoroethylene grafts for IARs in the IAS group (40% vs 15%;
χ2 test, P = .03). The 5-year primary patency rate for IARs was 68% in the IAS group, 46% in the IAA group, and 61%
in the AFB group. Univariate analyses revealed that primary patency rates for IARs in patients with previous IAS were
significantly higher than those in the IAA group (Kaplan-Meier, log-rank test, P = .02). Previous IAA repair was asso-
ciated with a two-fold increased risk of IAR graft failure (relative risk, 2.2; 95% CI, 1.1-4.8; P = .04).
Conclusions: IARs in patients with previous IAS have significantly improved graft patency, compared with those in patients
with previous IAA alone. Such graft patency for IAR after IAS is similar to that obtained after AFB repair. (J Vasc Surg
2001;34:971-8.)
to support any superiority of this approach over surgery.
Such consensus statements have not yet been widely used
in publications but clearly reflect the most current stan-
dard of evidence-based medicine.
This study investigated the influence of prior IAA and
stent placement for iliac occlusive disease on the outcome
of IARs, compared with those after IAA alone or
aortofemoral bypass (AFBs) grafting procedures. Defined
preoperative, procedural, and artery-specific factors that
are predictive of adverse results were considered. The most
current recommendations and standards were used to
define the different variables.13-15
METHODS
Between July 1995 and June 2000, 105 patients with
previous or concomitant intervention for iliac occlusive dis-
ease underwent 120 IARs at the University of Tennessee
Medical Center at Knoxville, and all were included in a ret-
rospective cohort study. All of the patients had evidence of
chronic limb ischemia. Demographic data, risk factors,
complications, and outcome variables were defined accord-
ing to the criteria prepared and revised by the Ad Hoc
Committee on Reporting Standards (Society for Vascular
Surgery/International Society for Cardiovascular Surgery
[SVS/ISCVS]).14,15 Patients who had undergone redo IAA
and/or stenting or IARs before the iliac reconstructive pro-
cedure were not included. Preoperative, intraoperative, and
follow-up information was available in all patients and was
obtained via office and hospital chart review, dictated oper-
ative records, and telephone conversations with patients,
physicians, or family members. The study protocol was
approved by the local institutional review board.
The endovascular procedures were performed in the
angiography suite by interventional radiologists after con-
sultation with the attending vascular surgeon, or in the
operating room by vascular surgeons. Arteriography was
performed by means of an ipsilateral or contralateral
femoral approach. Primary or selective stent placement
was performed at the discretion of the physician perform-
ing the procedure. A balloon-expandable Palmaz stent
(Cordis J and J, Warren, NJ) was used preferentially for
focal lesions, severely calcified lesions, and all lesions adja-
cent to the aortic bifurcation. A self-expandable Wallstent
(Boston Scientific Vascular, Boston, Mass) was usually
placed for long-segment disease or tortuous iliac arteries
and for contralateral approaches. A combination of the
two stents was generally used to provide extra length if the
lesion could not be completely covered by a Wallstent.
Stent placement was deemed technically successful if there
was less than a 30% residual stenosis and if the gradient
across the treated lesion was less than 5 mm Hg. Patients
in the surgical group had either aortobifemoral or aortobi-
iliac bypass procedures. Polyethylene terephthalate
(Hemashield, Boston Scientific, Oakland, NJ) (Dacron)
or polytetrafluoroethylene (PTFE) (Goretex, WL Gore &
Associates, Flagstaff, Ariz) grafts were used. Patients with
extra-anatomic bypass or unilateral aortoiliofemoral bypass
procedures were not included.
Assessment of aortoiliac and infrainguinal bypass grafts
patency was determined by using the SVS/ISCVS crite-
ria.14,15 There was no strict postoperative surveillance pro-
tocol. However, the patients were usually seen within 2
weeks after the time of the procedure. Improvement and
changes in clinical status were determined by history and
noninvasive vascular laboratory tests. At the discretion of
the attending surgeon, postoperative follow-up (clinical
and serial duplex ultrasound scanning examinations) was
conducted every 3 months during the first postoperative
year and every 6 months thereafter. Arteriography was
performed when duplex scanning revealed a decrease in
ankle/brachial index of 0.15 or more or if peak systolic
velocities were greater than 300 cm/second. Indications
for reintervention included a stenosis greater than 60%
and a gradient across the lesion greater than 15 mm Hg
with papaverine or greater than 10 mm Hg at rest. All
revisions performed based on these criteria or occlusion
were considered a stent failure and an end of primary
patency.14 Survival could be established by telephone con-
tact, but patency and limb salvage were determined at the
date of the most recent examination.
Variables analyzed included age, indication for the
procedure, extent of ischemia, comorbidities (diabetes
mellitus, hypertension, hyperlipidemia, coronary artery
disease, cerebrovascular disease, end-stage renal disease,
smoking history), runoff score, type of inflow reconstruc-
tion, location of the iliac lesion (common iliac vs external
iliac), type of graft conduit, and level of distal anastomo-
sis. The TASC classification of disease severity for iliac
lesions was used to define the categories of the lesions.13
Runoff was classified from preoperative and intraoperative
arteriograms (Ad Hoc Committee on Reporting stan-
dards, SVS/ISCVS).14,15 The angiographic runoff score
for IARs was used for subgroup analysis, categorizing
scores as poor runoff (score ≥5) and good runoff (score
<5). Infrainguinal bypass grafting procedures performed
within 30 days of stent placement were considered “con-
comitant procedures” to improve distal runoff.
Demographic data and risk factors were compared
between patients according to the previous iliac recon-
structive procedure (IAS, IAA, and AFB groups); univari-
ate analysis of categorical variables was performed using χ2
test (χ2 for independent groups, two-tailed P value).
Nonparametric tests were used for continuous variables
(Kruskal-Wallis one-way analysis of variance). All analyses
were performed according to the intention-to-treat princi-
ple. Primary patency, limb salvage, and patient survival
were determined with the Kaplan-Meier method and dif-
ferences with the log-rank test.16 Cox proportional haz-
ards model with time-dependent covariate was used for
multivariate analysis to assess the influence of various risk
factors on primary patency, limb salvage, and patient sur-
vival.17-19 Variables that had a P value less than .25 in the
univariate analysis and those known to be important or
possible confounding factors were entered into the regres-
sion model and considered significant by forward stepwise
selection if P was less than .05 in the final regression equa-
JOURNAL OF VASCULAR SURGERY
972 Timaran et al December 2001
tion. By this method, the relative risk (RR) and 95% con-
fidence intervals for the different variables were esti-
mated.17,18 For statistical analyses, SPSS for Windows
version 10.0 (SPSS Inc, Chicago, Ill) was used.19
RESULTS
The median patient age of the 105 patients was 62
years (range, 35-83 years). The median follow-up period
was 38 months, with a range of 3 to 63 months. The most
commonly associated risk factors in the overall group were
a significant history of tobacco use (86%), hypertension
(85%), coronary artery disease (74%), hyperlipidemia
(67%), and diabetes mellitus (52%). Other risk factors
included a history of chronic obstructive pulmonary dis-
ease (29%), cerebrovascular disease (22%), and end-stage
renal disease (4%). Indication for revascularization was
limb salvage in 90 procedures (75%) (ischemic rest pain in
22 [18%], tissue loss in 68 [57%]) and disabling claudica-
tion in 30 (25%). Autogenous vein was used in 66 IAR
procedures (55%), PTFE in 42 (35%), and 12 were PTFE-
vein composite grafts (10%). Twenty-seven IARs were
femoral to above-knee popliteal (22%), 43 femoral to
below-knee popliteal (36%), and 50 femorotibial (42%).
Most femoral to above-knee popliteal bypass reconstruc-
tions were performed with PTFE (27/30 [90%]), whereas
autogenous vein was mainly used for femoral to below-
knee popliteal and more distal procedures (75/90 [84%]).
Forty-five IARs were performed in patients with an
earlier IAS repair, 33 in patients with an earlier IAA repair,
JOURNAL OF VASCULAR SURGERY
Volume 34, Number 6 Timaran et al 973
and 42 in patients with an earlier AFB repair. Eighty-seven
IARs (82%) had a concurrent aortoiliac procedure,
whereas 33 had a previous inflow procedure, mostly
within 2 months (range, 0-28 months). Selective iliac
stenting was performed for the following indications: a
residual stenosis or pressure gradient after angioplasty
(75%), a dissection after balloon angioplasty (8%), or a
long segment occlusion (5%). Primary iliac stenting was
only performed in 6 procedures (11%). Palmaz stents were
used in 18 procedures (40%), Wallstents in 25 (56%), and
a combination of both in 2 (4%). Stents were placed in
three TASC type-A iliac lesions, 26 type-B lesions, 12
type-C lesions and 4 type-D lesions. IAA alone was per-
formed only for TASC types A and B, whereas AFB was
mostly performed for type D lesions (74%). In the AFB
group, there were 33 aortobifemoral grafts and three aor-
tobi-iliac bypass grafts. The transperitoneal approach was
used in 32 procedures, whereas the retroperitoneal
approach was used in four.
Initial technical success was obtained in 75 iliac
endovascular procedures (97%). Initial hemodynamic suc-
cess and clinical improvement, as defined by the
SVS/ISCVS reporting standards, was obtained in 95% of
patients.14 Forty-eight percent of patients had improved
to category +3, 38% to category +2, and 9% to category
+1. Two percent of patients were unchanged, whereas
three percent of patients were worse (category –1, 1%; cat-
egory –2, 1%; category –3, 1%). Eighteen patients (15%)
required revascularization of the contralateral extremity
Fig 1. IARs in patients with prior IAA alone had significantly decreased primary graft patency rates with
respect to those with previous IAS and AFB (Kaplan-Meier, log-rank test, P = .02).
during follow-up, with a median interval between proce-
dures of 9 months (range, 1-33 months). Wound infec-
tions developed in 11 patients (9%), but only three
patients (3) had deep infections that required drainage.
No graft infections occurred.
Univariate analyses revealed that the patients in the
AFB group were older and had more comorbidities. Female
sex, disabling claudication, use of PTFE for IAR, and poor
runoff were also risk factors more frequent in patients in the
AFB group. However, there were not significant differences
between the members of the IAS and IAA groups, except
for a more frequent use of PTFE grafts for IARs in the IAS
group (40% vs 15%; χ2 test, P = .03) (Table I). Iliac artery
occlusive disease also tended to be more extensive and mul-
tifocal in the IAS group, with more TASC type-C lesions
than in the IAA group (16% vs 1%; Fisher exact test, P =
.03). The frequency of external iliac artery (EIA) lesions
was similar between the IAS and IAA groups.
Cumulative primary patency rates for all infrainguinal
bypass procedures at 1, 3, and 5 years were 81%, 62%, and
59%, respectively. Primary patency rates at 1, 3, and 5
years were 89%, 75%, and 68%, respectively, for patients
with previous IAS, and 62%, 46%, and 46%, respectively,
for patients in the IAA group. Primary patency rates for
patients in the AFB group at 1, 3, and 5 years were 85%,
64%, and 61%, respectively. IARs in patients with previous
IAA alone had significantly decreased primary graft
patency rates with respect to those with previous IAS and
AFB (Fig 1) (Kaplan-Meier, log-rank test, P = .02).
Stratified analyses also revealed that IARs in patients with
EIA lesions also had decreased primary graft patency rates
compared with those in patients with only common iliac
artery lesions (Kaplan-Meier, log-rank test, P = .02).
Primary graft patency rates were not significantly different
for other risk factors analyzed such as patients’ sex, dia-
betes, history of smoking, hyperlipidemia, indication for
revascularization, type of conduit, level of distal anasto-
mosis, and distal runoff. Cox regression analysis revealed
that previous IAA was the only independent predictor of
decreased primary graft patency when controlling for the
presence of all other risk factors (RR, 2.2; 95% CI, 1.1-
4.8; P = .04) (Table I).
Cumulative aortoiliac primary patency rates at 1, 3,
and 5 years were 93%, 88%, and 88%, respectively, for
patients with previous IAS, 87%, 67%, and 67%, respec-
tively, for patients in the IAA group, and 98%, 96%, and
96%, respectively, for patients in the AFB group. Patients
with previous IAA alone had significantly decreased pri-
mary iliac patency rates with respect to those with previ-
ous IAS and AFB (Fig 2) (Kaplan-Meier, log-rank test, P
= .005). Interestingly, multivariate analyses revealed that
the use of PTFE for IARs and limb salvage was the only
independent predictor for decreased iliac primary patency
(Table II).
Graft thrombosis was the most frequent mechanism of
primary graft failure of IARs in patients with previous IAA
(10 of 13 graft failures [76%]) and was not as common in
patients with previous IAS (4 of 10 graft failures [40%]) or
JOURNAL OF VASCULAR SURGERY
974 Timaran et al December 2001
Fig 2. Patients with previous IAA alone had significantly decreased primary iliac patency rates with respect
to those with previous IAS and AFB (Kaplan-Meier, log-rank test, P = .005).
previous AFB (7 of 15 graft failures [47%]). Significant
graft stenosis was not demonstrated in patients who sub-
sequently developed graft thrombosis. Conversely, graft
stenosis accounted for most graft failures in patients with
previous IAS (55%) and AFB (53%), as compared with
IAA (23%).
For all patients, limb salvage at 1, 3, and 5 years was
99%, 97%, and 96%, respectively. Limb salvage analyses by
Kaplan-Meier and log-rank test revealed no significant dif-
ferences related to the previous aortoiliac reconstruction.
Two operative (30-day) deaths occurred, one in a patient
after a stroke in the AFB group and one after a myocardial
infarction in the IAA group. Overall, long-term survival
was 96% at 1 year, 92% at 3 years, and 84% at 5 years.
Cumulative patient survival was not statistically different
between patients in the three groups (Kaplan-Meier, log-
rank test, P = .72). No independent predictors for
decreased limb salvage or long-term survival were identi-
fied with multivariate analyses.
JOURNAL OF VASCULAR SURGERY
Volume 34, Number 6 Timaran et al 975
DISCUSSION
Several observational studies demonstrate that in
patients with lower-extremity ischemia and multilevel arte-
rial occlusive disease requiring combined revasculariza-
tion, aortobifemoral bypass remains the most effective
procedure for inflow revascularization.5,10,20 However,
the associated mortality and morbidity may be unaccept-
able, and aortoiliac surgical reconstruction is therefore
restricted to low-risk patients. New methods of improving
inflow have been introduced, and several studies have
shown that IAA may be performed with some success to
improve inflow for subsequent distal revascularization
procedures.6-8 Although few reports have described the
use of iliac stenting as an adjunct to IARs, the long-term
influence of iliac stent placement on the outcome of IARs
has not been defined.9-12
In this study, infrainguinal bypass graft primary
patency was significantly decreased in patients with previ-
Table I. Patient characteristics
Variable IAS group (%) (n = 45) IAA group (%) (n = 33) AFB group (%) (n = 42) P value
Median age 65 y 64 y 58 y <.001*
Female sex 15 (33) 14 (42) 27 (64) .01†
Comorbidities
Diabetes mellitus 19 (42) 15 (46) 28 (67) .05†
Hypertension 41 (91) 26 (79) 35 (83) NS
Smoking 39 (87) 25 (76) 39 (93) NS
Coronary artery disease 37 (82) 20 (61) 32 (76) NS
Renal insufficiency (Cr >1.6) 0 (0) 2 (12) 12 (28) <.001†
Indications
Claudication 7 (16) 7 (22) 16 (38) .003†
Rest pain 4 (9) 6 (18) 12 (28) .003†
Tissue loss 34 (75) 20 (60) 14 (34) .003†
Distal anastomosis
Above-knee popliteal 12 (27) 5 (15) 13 (31) NS
Below-knee popliteal 13 (28) 13 (39) 15 (36) NS
Tibial 20 (45) 15 (45) 14 (33) NS
Poor runoff (score >5) 7 (16) 8 (24) 16 (38) .05†
Graft conduit
In situ saphenous 13 (29) 15 (46) 12 (29) <.001†
Excised vein 4 (9) 11 (33) 11 (26) <.001†
PTFE 18 (40) 5 (15) 19 (45) <.001†
*Kruskal-Wallis one-way analysis of variance.
†χ2 analysis.
NS, Not significant; Cr, creatinine level.
Table II. Independent predictors of primary patency*
Coefficient RR† 95% CI P value
IAR primary graft patency
IAA 0.793 2.2 1.1-4.8 .04
Aortoiliac primary patency
IAR with prosthetic graft (PTFE) 1.917 6.8 2.1-22.9 .002
Limb salvage 1.256 3.5 1.1-11.4 .003
*Variables with a P value <.1 with the univariate analysis were entered into the multivariate Cox regression models with time-dependent covariates and
selected by forward stepwise selection if P value <.05 (P < .001 for models).
95 % CI, 95% confidence interval.
†RR of decreased primary patency.
ous IAA alone, compared with that in patients who had
undergone IAS or AFB repair for aortoiliac occlusive dis-
ease. Moreover, IAA was the only independent predictor
of decreased IARs primary graft patency. Despite the fact
that most of the IARs in the IAA group were performed
with autogenous vein grafts and that less severe iliac
lesions were also more frequent in this group, the out-
come of concurrent IARs was poor with significantly
lower primary graft patency. We could not demonstrate
any significant contribution of other risk factors to such
results. Because IAA patency changes across time, ie, the
hazard ratios are different at different time points, an
extended Cox regression model, which allowed us to spec-
ify time-dependent covariates, was used for the multivari-
ate analyses.19 We established that the patency of the
inflow procedure, in particular IAA alone, was the only
independent predictor of IAR primary graft failure.
Inflow failure can be implied as the mechanism of graft
failures of IARs in patients with previous IAA because no
previous graft abnormalities were evident apart from a
lower iliac primary patency. This finding correlates with
experiences previously reported that indicate that inflow
failure appears to account for infrainguinal bypass graft
failure.11 Although IAR primary patency after IAA
appeared to be lower in our series than previously
reported, this may be related to the higher frequency of
limb salvage as the indication for the procedures and the
more frequent use of prosthetic grafts.7,8
IAS was associated with a significant improvement of
IAR primary graft patency and was comparable to that
observed after AFB repair. Although iliac primary patency
after IAA and stenting was reduced compared with that in
patients with AFB repair, this did not appear to affect the
IAR primary graft patency. In this series, selective iliac
stenting was performed in most procedures for unsatisfac-
tory or complicated IAA. Stratified analyses to determine
the influence of primary iliac stenting on the outcome of
IARs were subject to a type II statistical error because of
the small number of patients and could not be obtained.
Our results, however, favor primary iliac stenting for iliac
lesions when combined IARs are also required.
Although not statistically significant, there was a trend
toward more frequent stent placement for iliac lesions
among men, which may account for the higher primary
stent patency after IAS observed in this group than previ-
ously reported.2,3,13
EIA stenting has been identified as a risk factor for iliac
stent failure, in particular in patients with multisegmental
iliac occlusive disease.21,22 Interestingly, in our series EIA
stenting was also associated with a significantly reduced
IAR primary graft patency. Although in the multivariate
analysis model, EIA stenting was not an independent pre-
dictor for IAR graft failure, this may be related to a type II
statistical error.
Prosthetic grafts were used preferentially for above-
knee popliteal bypass procedures and patients with dis-
abling claudication and whenever an autogenous vein graft
was not available. Unexpectedly, however, the use of
PTFE grafts for IARs was an independent predictor of
reduced iliac primary patency in all groups. Our results
therefore favor the use of venous reconstructions in
patients who need multilevel arterial reconstructions, even
for patient with claudication who may need above-knee
popliteal bypass procedures.
AFB repair was restricted to patients with lower oper-
ative risk, and this may account for the lower morbidity
and mortality observed in this group. Although patients in
the AFB group had a higher frequency of comorbidities,
female sex, use of PTFE for IAR, and poor runoff, the
outcome of IARs did not appear to be affected. Our data
indicate that in carefully selected patients, AFB as an
adjunct of IARs offers optimal results.
Because of the small number of patients, the possibil-
ity of a type II statistical error was considered. A post hoc
power analysis was then obtained to determine the β error
and was based on previous studies.1-8,11,12 The sample size
calculation was stratified to the data set including only
patients with previous IAA and IAS and was large enough
to obtain at least 80% power, with a two-sided type I error
rate of 0.05, to detect a difference in the 5-year primary
patency rates of IARs from 68% in patients with previous
IAS to 46% in patients in the IAS group (RR, 2.2).
In conclusion, IARs in patients with previous IAS have
significantly improved graft patency as compared with
those in patients with previous IAA alone. Such graft
patency for IAR after IAS is similar to that obtained after
AFB repair. Although our results favor primary iliac stent-
ing for iliac lesions when a combined IAR is also required,
further studies are necessary to assess the efficacy of such
an approach.
REFERENCES
1. Johnston KW. Iliac arteries: reanalysis of results of balloon angioplasty.
Radiology 1993;186:207-12.
2. Hood DB, Hodgson KJ. Percutaneous transluminal angioplasty and
stenting for iliac artery occlusive disease. Surg Clin North Am
1999;79:575-96.
3. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous
transluminal angioplasty and stent placement for aortoiliac occlusive
disease. Radiology 1997;204:87-96.
4. de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aor-
toiliac occlusive disease: a meta-analysis. J Vasc Surg 1997;26:558-69.
5. Brewster DC, Perler BA, Robison JG, Darling RC. Aortofemoral graft
for multilevel occlusive disease. Predictors of success and need for dis-
tal bypass. Arch Surg 1982;117:1593-600.
6. Brewster DC, Cambria RP, Darling RC, Athanasoulis CA, Waltman
AC, Geller SC, et al. Long-term results of combined iliac balloon
angioplasty and distal surgical revascularization. Ann Surg 1989;210:
324-30.
7. Peterkin GA, Belkin M, Cantelmo NL, Guben J, Greenfield AJ,
Johnson WC, et al. Combined transluminal angioplasty and infrain-
guinal reconstruction in multilevel atherosclerotic disease. Am J Surg
1990;160:277-9.
8. Siskin G, Darling RC III, Stainken B, Chang BB, Paty PS, Kreienberg
PB, et al. Combined use of iliac artery angioplasty and infrainguinal
revascularization for treatment of multilevel atherosclerotic disease.
Ann Vasc Surg 1999;13:45-51.
9. Demasi RJ, Snyder SO, Wheeler JR, Gregory RT, Gayle RG, Parent
FN, et al. Intraoperative iliac artery stents: combination with infra-
inguinal revascularization procedures. Am Surg 1994;60:854-9.
JOURNAL OF VASCULAR SURGERY
976 Timaran et al December 2001
10. Marin ML, Veith FJ, Sanchez LA, Cynamon J, Suggs WD, Schwartz
ML, et al. Endovascular aortoiliac grafts in combination with standard
infrainguinal arterial bypasses in the management of limb-threatening
ischemia: preliminary report. J Vasc Surg 1995;22:316-24.
11. Eagleton MJ, Illig KA, Green RM, Ouriel K, Riggs PN, DeWeese JA.
Impact of inflow reconstruction on infrainguinal bypass. J Vasc Surg
1997;26:928-36.
12. Lau H, Cheng SW. Intraoperative endovascular angioplasty and stent-
ing of iliac artery: an adjunct to femoro-popliteal bypass. J Am Coll
Surg 1998;186:408-14.
13. Dormandy JA, Rutherford RB. Management of peripheral arterial dis-
ease (PAD). TASC Working Group. TransAtlantic Inter-Society
Concensus (TASC). J Vasc Surg 2000;31:S1-S296.
14. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S,
et al. Recommended standards for reports dealing with lower extrem-
ity ischemia: revised version. J Vasc Surg 1997;26:517-38.
15. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW,
McClean GK, et al. Reporting standards for lower extremity arterial
endovascular procedures. Society for Vascular Surgery/International
Society for Cardiovascular Surgery. J Vasc Surg 1993;17:1103-7.
JOURNAL OF VASCULAR SURGERY
Volume 34, Number 6 Timaran et al 977
16. Kaplan EL, Meier P. Non-parametric estimation from incomplete
observations. J Am Stat Assoc 1958;53:457-81.
17. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:
187-220.
18. Christensen E. Multivariate survival analysis using Cox’s regression
model. Hepatology 1987;7:1346-58.
19. SPSS 9.0. Advanced Models. Chicago (IL): Statistical Package for the
Social Sciences; 1999.
20. Harris PL, Bigley DJ, McSweeney L. Aortofemoral bypass and the
role of concomitant femorodistal reconstruction. Br J Surg 1985;72:
317-20.
21. Powell RJ, Fillinger M, Walsh DB, Zwolak R, Cronenwett JL.
Predicting outcome of angioplasty and selective stenting of multiseg-
ment iliac artery occlusive disease. J Vasc Surg 2000;32:564-9.
22. Powell RJ, Fillinger M, Bettmann M, Jeffery R, Langdon D, Walsh
DB, et al. The durability of endovascular treatment of multisegment
iliac occlusive disease. J Vasc Surg 2000;31:1178-84.
Submitted May 14, 2001; accepted Jul 27, 2001.
Dr Keith D. Calligaro (Philadelphia, Penn). The authors
compared differences in lower-extremity bypass patency rates fol-
lowing iliac artery balloon angioplasty alone, iliac artery stenting,
or aortobifemoral bypass. The 5-year primary patency rates for
lower-extremity bypasses were significantly better in patients pre-
viously treated by iliac stenting or aortobifemoral bypass compared
to iliac balloon angioplasty alone. Iliac artery stenting yielded
higher bypass patency rates compared to balloon angioplasty
alone, despite the fact that these stents were placed in patients with
more advanced iliac artery disease and in patients who more fre-
quently had a prosthetic graft in place. So that’s pretty impressive.
And I think the take-home message the authors are getting at is
that previous reports have suggested that stenting yields better
iliac patency rates than a balloon alone. And they’re saying not
only that, but iliac stenting will yield higher lower-extremity
bypass patency rates, which is a different way to look at it.
I have three questions.
1. You found that the patients who had prosthetic leg bypasses
had lower iliac artery patency rates if the iliac arteries had been
ballooned or stented. Why should the presence of a prosthetic
leg bypass cause a decreased iliac artery balloon patency rate?
2. What is your opinion regarding iliac artery balloon angio-
plasty performed at the same time as lower-extremity revas-
cularization? In the manuscript you defined “concomitant”
as an iliac artery balloon or stent performed within 30 days
of the lower-extremity bypass. I think most of us think of
“concomitant” as “simultaneous”; in other words, the bal-
loon is done at the same operative setting as a leg bypass. Our
vascular fellow, Laurence Young, and one of our associates,
Matt Dougherty, compiled our experience at Pennsylvania
Hospital with 110 endovascular procedures performed con-
comitantly, or simultaneously, with lower-extremity revascu-
larizations, and we found that only a very small number of
lower-extremity bypasses failed because of restenosis at the
site treated endovascularly. And we believe that the strategy
of concomitant procedures is more cost-efficient and conve-
nient for the patient.
3. My last question: I’d like to propose the following case to you.
A 65-year-old male underwent a common iliac artery balloon
angioplasty a year ago and now requires a fem-tib bypass. An
arteriogram demonstrates a widely patent iliac artery where the
balloon was performed. Would you now stent this widely patent
iliac artery or not? Your paper suggests that you would, but com-
mon sense suggests that would you leave well enough alone.
Thank you for the opportunity to discuss the paper.
Dr Carlos H. Timaran. Thank you, Dr Calligaro, for your
comments and your thoughtful questions.
The first question, why the use of prosthetic graft affected
aortoiliac primary patency, is actually something that we don’t
know. We were also surprised when our multivariate analysis mod-
els revealed that this was an independent predictor for decreased
primary patency for the aortoiliac segment. Unfortunately, our
sample size was small, and although additional stratified analyses
were attempted, we always had the problem of a type II statistical
error that prevented us from identifying additional factors that
could play a role in these findings.
About two thirds of the inflow procedures were performed
simultaneously with the distal revascularization procedures in the
operating room by vascular surgeons.
In regard to the case you presented to us, I think that what is
really important is to have a good inflow. The problem with iliac
angioplasty alone is that the risk of early restenosis is higher, and that
is probably one of the factors that accounts for the decreased pri-
mary patency that we observed in our infrainguinal revascularization
procedures. But in the patient you are describing, probably the
inflow is good enough to just perform the distal revascularization
procedure without any other additional proximal or suprainguinal
procedure. Measuring a pressure gradient across the previous iliac
lesion may also aid in determining the need for stent placement.
Dr Daniel Clair (Cleveland, Ohio). I’d like to congratulate
you for a nicely presented paper. I just have a couple of questions
for you about techniques.
One of the things that I think is a problem when we’re eval-
uating angioplasty results with pressure gradients across the
stenosis to decide whether to place a stent, is the outflow after
the vessel has been treated. If the angioplasties are done before
the outflow has been restored, essentially what you’re doing is
measuring a pressure gradient across a closed tube, so you can’t
really assess as to whether there is a true pressure gradient across
the lesion that you’ve just treated. My own preference is to per-
form angioplasty or the stent after the distal bypass has been
done so that we get a true sense of what the outflow of that ves-
sel is going to be. I would wonder as to whether this evaluation
was done before or after the outflow procedure has been done.
Secondly, it looks like from your data that basically it’s the
iliac angioplasty failure that really is what you’re reporting on. I
may be misreading the graphs that you presented, but it appears
that if iliac angioplasty fails, not very surprisingly the outflow pro-
cedure fails as well. Is there more to it than just this?
Thanks.
DISCUSSION
Dr Timaran. We do agree that pressure gradients are really
important to define if a patient needs additional stent placement.
Seventy-five percent of our patients underwent stent placement
for significant residual stenosis or pressure gradients.
We certainly divided primary patency rates in two different
segments. One was the primary patency for the infrainguinal
reconstruction grafts, and the other one was the aortoiliac pri-
mary patency. We found that the aortoiliac primary patency was
always higher than the distal primary patency. However, failure of
the proximal aortoiliac segment did not always account for failure
of the distal bypass procedures.
Dr Timur P. Sarac (Cleveland, Ohio). Carlos, I enjoyed your
presentation. The ultimate result I think that we’d like to look at
is limb salvage. And certainly improving the inflow may help the
bypass stay open long enough to heal the ulcer or improve the
rest pain or even develop collaterals. But can you comment at all
on your long-term limb salvage for this, because that’s really what
the patient is looking at.
Dr Timaran. We focused our paper on the primary patency
rates. But you are right, secondary patency rates were actually
much higher and similar to the limb salvage rates. And the reason
is that many of the patients with procedures that fail, for example,
those with iliac angioplasty alone, underwent iliac angioplasty and
stenting later on, whereas other patients underwent surgical
reconstructions.
We think that primary patency rates are important because
they determine the initial outcome and in this way the initial pro-
cedure that’s best for the patients.
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